Therapeutic management and clinical outcome of autoimmune pancreatitis

Scandinavian Journal of Gastroenterology

Volumn 46, Issue 9, 2011, Pages 1029-1038

  Pezzilli, Raffaele ^a   Cariani, Giulio ^a   Santini, Donatella ^a   Calculli, Lucia ^a   Casadei, Riccardo ^a   Morselli Labate, Antonio Maria ^a   Corinaldesi, Roberto ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Autoimmune pancreatitis; Outcome; Pancreatitis; Therapy

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; IMMUNOGLOBULIN G4; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; PREDNISONE; RITUXIMAB; STEROID; URSODEOXYCHOLIC ACID;

ABDOMINAL PAIN; ANTIBIOTIC THERAPY; AUTOIMMUNE PANCREATITIS; BARE METAL STENT; BILE DUCT OBSTRUCTION; BONE MARROW SUPPRESSION; CATARACT; COMPUTER ASSISTED TOMOGRAPHY; CORTICOSTEROID THERAPY; DIABETES MELLITUS; DIARRHEA; DISEASE ASSOCIATION; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG INDUCED HEADACHE; DRUG PULSE THERAPY; ERADICATION THERAPY; HELICOBACTER INFECTION; HUMAN; HYDRONEPHROSIS; HYPERTENSION; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; INTERSTITIAL NEPHRITIS; LEUKOPENIA; LIVER TOXICITY; MAINTENANCE THERAPY; NAUSEA; OBSTRUCTIVE JAUNDICE; OSTEOPOROSIS; PANCREAS PSEUDOCYST; PANCREATICODUODENECTOMY; PANCREATITIS; PATIENT SELECTION; PERIPHERAL EDEMA; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PSEUDOCYST; REMISSION; RETROPERITONEAL FIBROSIS; REVIEW; SICKLE CELL CRISIS; SIDE EFFECT; SJOEGREN SYNDROME; SYMPTOMATOLOGY; TREATMENT DURATION; TREATMENT OUTCOME;

ANTI-INFLAMMATORY AGENTS; AUTOIMMUNE DISEASES; DIABETES COMPLICATIONS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PANCREATITIS; PREDNISONE;

EID: 80051718539     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2011.584896     Document Type: Review

References (60)

1. Rao AS, Palazzo F, Chung J, Hager E, Abdollahi H, Yeo CJ. Diagnostic and treatment modalities for autoimmune pancreatitis. Curr Treat Options Gastroenterol 2006;9: 377-84. (Pubitemid 44468616)
2. Kamisawa T, Nakajima H, Egawa N, Funata N, Tsuruta K, Okamoto A. IgG4-related sclerosing disease incorporating sclerosing pancreatitis, cholangitis, sialadenitis and retroper-itoneal fibrosis with lymphadenopathy. Pancreatology 2006; 6:132-7.
3. Matsushita M, Yamashina M, Ikeura T, Shimatani M, Uchida K, Takaoka M, Okazaki K. Effective steroid pulse therapy for the biliary stenosis caused by autoimmune pancreatitis. Am J Gastroenterol 2007;102:220-1. (Pubitemid 46072085)
4. Hamano H, Arakura N, Muraki T, Ozaki Y, Kiyosawa K, Kawa S. Prevalence and distribution of extrapan-creatic lesions complicating autoimmune pancreatitis. J Gastroenterol 2006;41:1197-205. (Pubitemid 46487210)
5. Pezzilli R, Morselli-Labate AM. The concept of autoimmune pancreatitis and its immunological backgrounds. Exp Rev Clin Immunol 2010;6:125-36.
6. Chari ST, Kloeppel G, Zhang L, Notohara K, Lerch MM, Shimosegawa T. Histopathologic and clinical subtypes of autoimmune pancreatitis: the Honolulu consensus document. Pancreatology 2010;10:664-72.
7. Shimosegawa T, Chari ST, Frulloni L, Kamisawa T, Kawa S, Mino-Kenudson M, et al. International Consensus Diagnostic Criteria for Autoimmune Pancreatitis: Guidelines of the International Association of Pancreatology. Pancreas 2011;40:352-8.
8. Toomey DP, Swan N, Torreggiani W, Conlon KC. Autoimmune pancreatitis: medical and surgical management. JOP 2007;8:335-43. (Pubitemid 46876794)
9. Klöppel G, Lüttges J, Löhr M, Zamboni G, Longnecker D. Autoimmune pancreatitis: pathological, clinical, and immu-nological features. Pancreas. 2003;27:14-19.
10. Zamboni G, Lüttges J, Capelli P, Frulloni L, Cavallini G, Pederzoli P, et al. Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens. Virchows Arch 2004;445:552-63. (Pubitemid 40104530)
11. Abraham SC, Wilentz RE, Yeo CJ, Sohn TA, Cameron JL, Boitnott JK, Hruban RH. Pancreaticoduodenectomy (Whip-ple resections) in patients without malignancy: are they all 'chronic pancreatitis'? Am J Surg Pathol 2003;27:110-320.
12. Pezzilli R, Casadei R, Calculli L, Santini D. Autoimmune pancreatitis. A case mimicking carcinoma JOP 2004;5: 527-30.
13. Watanabe M, Yamaguchi K, Kobayashi K, Konomi H, Nakamura M, Mizumoto K, et al. Autoimmune pancreatitis diagnosed after pancreatoduodenectomy and successfully treated with low-dose steroid. J Hepatobiliary Pancreat Surg 2007;14:397-400. (Pubitemid 47190062)
14. Padilla D, Cubo T, Villarejo P, Pardo R, Jara A, de la Plaza R, Hernández J. Response to steroid therapy of sclerosing cholangitis after duodenopancreatectomy due to autoimmune pancreatitis. Gut 2005;54:1348-9. (Pubitemid 41192508)
15. Schnelldorfer T, Lewin DN, Adams DB. Long-term results after surgery for autoimmune sclerosing pancreatitis. J Gastrointest Surg 2007;11:56-8.
16. Weber SM, Cubukcu-Dimopulo O, Palesty JA, Suriawinata A, Klimstra D, Brennan MF, Conlon K. Lymphoplasmacytic sclerosing pancreatitis: Inflammatory mimic of pancreatic carcinoma. J Gastrointest Surg 2003; 7:129-39. (Pubitemid 36875810)
17. Okazaki K. Ursodeoxycholic acid as an alternative therapy for autoimmune pancreatitis. Intern Med 2002;41:1082-3. (Pubitemid 36149998)
18. Pezzilli R, Casadei R, Santini D. Autoimmune pancreatitis associated with anisakis infection. Dig Liver Dis 2007;39: 273. (Pubitemid 46196433)
19. Ozden I, Dizdaroglu F, Poyanli A, Emre A. Spontaneous regression of a pancreatic head mass and biliary obstruction due to autoimmune pancreatitis. Pancreatology 2005;5: 300-3. (Pubitemid 40754754)
20. Araki J, Tsujimoto F, Ohta T, Nakajima Y. Natural course of autoimmune pancreatitis without steroid therapy showing hypoechoic masses in the uncinate process and tail of the pancreas on ultrasonography. J Ultrasound Med 2006;25: 1063-7. (Pubitemid 44157339)
21. Hirano K, Tada M, Isayama H, Yagioka H, Sasaki T, Kogure H, et al. Long-term prognosis of autoimmune pancreatitis with and without corticosteroid treatment. Gut 2007;56:1719-24. (Pubitemid 350206299)
22. Kamisawa T, Anjiki H, Takuma K, Egawa N, Kubota N. The natural course of autoimmune pancreatitis. Hepatogastroen-terology 2009;56:866-70.
23. Chari ST. Current concepts in the treatment of autoimmune pancreatitis. JOP 2007;8:1-3. (Pubitemid 46157762)
24. Fantini L, Zanini N, Fiscaletti M, Calculli L, Casadei R, Campana D, Pezzilli R. Autoimmune pancreatitis: the classification puzzle. Adv Med Sci 2007;52:71-5.
25. Matsubayashi H, Imai K, Kusumoto K, Ono H. Suspected autoimmune pancreatitis-An indication for steroid treatment? Dig Liver Dis 2010;42:525-6.
26. Zamboni G, Capelli P, Scarpa A, Bogina G, Pesci A, Brunello E, Klöppel G Nonneoplastic mimickers of pancreatic neoplasms. Arch Pathol Lab Med 2009;133: 439-53.
27. Otsuki M. Autoimmune pancreatitis: a message from Japan. J Gastroenterol 2007;42 (Suppl XVIII):1-5. (Pubitemid 46863929)
28. Okazaki K, Chiba T. Autoimmune related pancreatitis. Gut 2002;51:1-4. (Pubitemid 34717730)
29. Pezzilli R. Acute recurrent pancreatitis: an autoimmune disease? World J Gastroenterol 2008;14:999-1006. (Pubitemid 351324996)
30. Tsubakio K, Kiriyama K, Matsushima N, Taniguchi M, Shizusawa T, Katoh T, et al. Autoimmune pancreatitis successfully treated with ursodeoxycholic acid. Intern Med 2002;41:1142-6. (Pubitemid 36150014)
31. Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 2001; 344:732-8. (Pubitemid 32204991)
32. Nishino T, Toki F, Oyama H, Oi I, Kobayashi M, Takasaki K, Shiratori K. Biliary tract involvement in autoimmune pancreatitis. Pancreas 2005;30:76-82. (Pubitemid 40070630)
33. Kamisawa T, Yoshiike M, Egawa N, Nakajima H, Tsuruta K, Okamoto A. Treating patients with autoimmune pancreatitis: results from a long-term follow-up study. Pancreatology 2005;5:234-8. (Pubitemid 40754743)
34. Takayama M, Hamano H, Ochi Y, Saegusa H, Komatsu K, Muraki T, et al. Recurrent attacks of autoimmune pancreatitis result in pancreatic stone formation. Am J Gastroen-terol 2004;99:932-7. (Pubitemid 39090226)
35. Tanaka S, Kobayashi T, Nakanishi K, Okubo M, Murase T, Hashimoto M, Takeuchi K. Corticosteroid-responsive diabetes mellitus associated with autoimmune pancreatitis. Lancet 2000;356:910-11.
36. Nobili E, Pezzilli R, Santini D, Campidelli C, Calculli L, Casadei R, et al. Autoimmune pancreatitis associated with high levels of chromogranin A, serotonin and 5-hydroxy indoleacetic acid. Case Rep Gastroenterol 2008;2:11-17.
37. Horiuchi A, Kawa S, Hamano H, Hayama M, Ota H, Kiyosawa K. ERCP features in 27 patients with autoimmune pancreatitis. Gastrointest Endosc 2002;55:494-9. (Pubitemid 41123499)
38. Sah RP, Pannala R, Chari ST, Sugumar A, Clain JE, Levy MJ, et al. Prevalence, diagnosis, and profile of autoimmune pancreatitis presenting with features of acute or chronic pancreatitis. Clin Gastroenterol Hepatol 2010;8: 91-6.
39. Ghazale A, Chari ST. Optimising corticosteroid treatment for autoimmune pancreatitis. Gut 2007;56:1650-2. (Pubitemid 350206287)
40. Rueda JC, Duarte-Rey C, Casas N. Successful treatment of relapsing autoimmune pancreatitis in primary Sjögren's syndrome with Rituximab: report of a case and review of the literature. Rheumatol Int 2009;29:1481-5.
41. Miyatani H, Yoshida Y, Ikeda M, Sagihara N. Improvement of thrombocytopenia in a patient with autoimmune pancreatitis after Helicobacter pylori eradication. Intern Med 2008; 47:321-2. (Pubitemid 351377300)
42. Manfredi R, Graziani R, Cicero C, Frulloni L, Carbognin G, Mantovani W, Mucelli RP. Autoimmune pancreatitis: CT patterns and their changes after steroid treatment. Radiology 2008;247:435-43.
43. Sahani DV, Sainani NI, Deshpande V, Shaikh MS, Frinkelberg DL, Fernandez-del Castillo C. Autoimmune pancreatitis: disease evolution, staging, response assessment, and CT features that predict response to corticosteroid therapy. Radiology 2009;250:118-29.
44. Morselli-Labate AM, Pezzilli R. Usefulness of serum IgG4 in the diagnosis and follow up of autoimmune pancreatitis: A systematic literature review and meta-analysis. J Gastroenterol Hepatol 2009;24:15-36.
45. Nishimori I, Tamakoshi A, Kawa S, Tanaka S, Takeuchi K, Kamisawa T, et al. Research Committee on Intractable Pancreatic Diseases, the Ministry of Health and Welfare of Japan. Influence of steroid therapy on the course of diabetes mellitus in patients with autoimmune pancreatitis: findings from a nationwide survey in Japan. Pancreas 2006; 32:244-8.
46. Tanaka S, Kobayashi T, Nakanishi K, Okubo M, Odawara M, Murase T, et al. Corticosteroid-responsive diabetes mellitus associated with autoimmune pancreatitis: pathological examinations of the endocrine and exocrine pancreas. Ann NY Acad Sci 2002;958:152-9. (Pubitemid 34592217)
47. Kahaleh M, Behm B, Clarke BW, Brock A, Shami VM, De La Rue SA, et al. Temporary placement of covered self-expandable metal stents in benign biliary strictures: a new paradigm? (with video). Gastrointest Endosc 2008; 67:446-54. (Pubitemid 351253635)
48. Mahajan A, Ho H, Sauer B, Phillips MS, Shami VM, Ellen K, et al. Temporary placement of fully covered self-expandable metal stents in benign biliary strictures: midterm evaluation (with video). Gastrointest Endosc 2009;70:303-9.
49. Pezzilli R, Broccoli PL, Melandri R, Vandelli A, Re G, Fontana G. Exocrine pancreatic involvement in Wegener's granulomatosis. A case report. Ital J Gastroenterol 1991;23: 258-60.
50. Toomey DP, Swan N, Torreggiani W, Conlon KC. Autoimmune pancreatitis. Br J Surg 2007;94:1067-74. (Pubitemid 350082849)
51. Nishino T, Toki F, Oyama H, Shimizu K, Shiratori K. Long-term outcome of autoimmune pancreatitis after oral prednisolone therapy. Intern Med 2006;45:497-501.
52. Kamisawa T, Okamoto A, Wakabayashi T, Watanabe H, Sawabu N. Appropriate steroid therapy for autoimmune pancreatitis based on long-term outcome. Scand J Gastro-enterol 2008;43:609-13. (Pubitemid 351536059)
53. Frulloni L, Scattolini C, Falconi M, Zamboni G, Capelli P, Manfredi R, et al. Autoimmune pancreatitis: differences between the focal and diffuse forms in 87 patients. Am J Gastroenterol 2009;104:2288-94.
54. Borum M, Steinberg W, Steer M, Freedman S, White P. Chronic pancreatitis: a complication of systemic lupus erythematosus. Gastroenterology 1993;104:613-15. (Pubitemid 23033438)
55. Wakabayashi T, Kawaura Y, Satomura Y, Fujii T, Motoo Y, Okai T, Sawabu N. Clinical study of chronic pancreatitis with focal irregular narrowing of the main pancreatic duct and mass formation: comparison with chronic pancreatitis showing diffuse irregular narrowing of the main pancreatic duct. Pancreas 2002;25:283-9.
56. Hardacre JM, Iacobuzio-Donahue CA, Sohn TA, Abraham SC, Yeo CJ, Lillemoe KD, et al. Results of pan-creaticoduodenectomy for lymphoplasmacytic sclerosing pancreatitis. Ann Surg 2003;237:853-8.
57. Fernandez-del Castillo CF, Sahani DV, Brugge WR, Harris NL, Warshaw AL, Lauwers GY, et al. Case records of the Massachusetts General Hospital. Weekly clinicopatho-logical exercises. Case 27-2003. A 36-year-old man with recurrent epigastric pain and elevated amylase levels. N Engl J Med 2003;349:893-901. (Pubitemid 37025410)
58. Tanvetyanon T, Stiff PJ. Recurrent steroid-responsive pancreatitis associated with myelodysplastic syndrome and transformations. Leuk Lymphoma 2005;46:151-4.
59. Wayne M, Delman KA, Kurt T, Grossi R, Sabatini M, Cooperman A. Autoimmune pancreatitis: unveiling a hidden entity. Arch Surg 2005;140:1104-7. (Pubitemid 41668681)
60. Abisi S, Morris-Stiff G, Hill SM, Roberts A, Williams G, Puntis MC. Autoimmune pancreatitis: an underdiagnosed condition in Caucasians. J Hepatobiliary Pancreat Surg 2005; 12:332-5. (Pubitemid 41258736)